Table 4.
List of VIP polar lipids from the PLS-DA model based on male samples only.
| Lipid Name | Adduct | Retention Time | m/z | PLS-DA VIP | FC A-K | FC D-K |
|---|---|---|---|---|---|---|
| FAHFA (14:0/16:2) | [M − H]− | 3.439 | 477.3908 | 2.81 | 0.34 | 0.05 |
| FAHFA (16:1/18:3) | [M − H]− | 3.614 | 529.4225 | 2.58 | 0.36 | 0.13 |
| FAHFA (20:4/18:3) | [M − H]− | 3.626 | 579.4376 | 2.28 | 0.47 | 0.20 |
| LPC (20:3) | [M + H]+ | 3.948 | 546.3583 | 2.25 | 0.75 | 0.78 |
| FAHFA (18:1/20:3) | [M − H]− | 5.205 | 585.4851 | 2.02 | 0.50 | 0.19 |
| LPE (18:2) | [M − H]− | 2.315 | 476.2774 | 1.87 | 1.17 | 0.83 |
| LPC (20:3) | [M + H]+ | 3.630 | 546.3580 | 1.78 | 0.80 | 0.91 |
| LPC (20:5) | [M + H]+ | 2.239 | 542.3265 | 1.75 | 1.15 | 0.65 |
| LPC (18:3) | [M + H]+ | 1.915 | 518.3277 | 1.74 | 1.41 | 0.70 |
| FAHFA (18:2/20:4) | [M − H]− | 3.932 | 581.4535 | 1.73 | 0.70 | 0.51 |
| LPC (20:1) | [M + H] | 4.024 | 550.3911 | 1.64 | 0.80 | 0.91 |
| LPE (20:4) | [M − H]− | 2.218 | 500.2774 | 1.59 | 0.94 | 0.60 |
| FAHFA (18:0/20:2) | [M − H]− | 6.278 | 589.5155 | 1.56 | 0.90 | 1.01 |
| LPC (18:2) | [M + H]+ | 2.240 | 520.3443 | 1.49 | 1.09 | 0.69 |
| LPC (22:6) | [M + H]+ | 2.450 | 568.3420 | 1.38 | 1.04 | 0.62 |
| LPC (22:5) | [M + H]+ | 2.435 | 570.3590 | 1.36 | 0.94 | 0.55 |
| FAHFA (18:1/18:2) | [M − H]− | 4.983 | 559.4692 | 1.36 | 0.86 | 0.94 |
| FAHFA (18:1/20:3) | [M − H]− | 5.205 | 585.4851 | 1.31 | 0.83 | 0.94 |
| LPC (22:6) | [M + H]+ | 2.020 | 568.3428 | 1.30 | 0.75 | 0.49 |
| LPC (22:5) | [M + H]+ | 2.214 | 570.3590 | 1.30 | 0.87 | 0.57 |
| FAHFA (16:0/18:2) | [M − H]− | 4.893 | 533.4541 | 1.30 | 0.82 | 0.90 |
| LPE (22:6) | [M − H]− | 2.092 | 524.2771 | 1.29 | 0.95 | 0.61 |
| LPE (18:1) | [M − H]− | 2.967 | 478.2928 | 1.25 | 1.22 | 1.00 |
| LPC (20:2) | [M + H]+ | 3.028 | 548.3753 | 1.06 | 1.02 | 0.76 |
| LPC (20:3) | [M + H]+ | 2.640 | 546.3598 | 1.06 | 1.02 | 0.71 |